<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Incyte Corp. | Company News & Executive Profiles - INCY | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/incyte+corp..html]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Incyte Corp.]]></description>
	<s:counts start="0" returned="10" found="20" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Incyte's Collaboration with Novartis AG Presents Great Opportunity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175906-incyte-s-collaboration-with-novartis-ag-presents-great-opportunity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Incyte Corporation INCY entered into a collaboration and license agreement with Novartis AG NVS regarding two of its pipeline candidates &#8211; INCB18424, an oral JAK1/JAK2 inhibitor and INCB28060, an oral cMET inhibitor. While the former is currently being studied in a phase III clinical trial for...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 05:45:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">INCY,NVS</category>
	</item>
	<item>
		<title><![CDATA[Incyte Corporation Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-361496.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions  Your first call comes from Tom Russo &#8211; Robert W. Baird.   Tom Russo &#8211; Robert W. Baird & Company I'm guessing you probably won't want to set any explicit guidance on timing or partnership, but could you characterize just any of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 05 Nov 2009 10:53:12 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/robert+w.+baird+%2526+co..html"><![CDATA[Robert W. Baird & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Incyte Corporation Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152573-incyte-corporation-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Incyte Corporation INCY   Q2 2009 Earnings Call Transcript   July 30, 2009 8:30 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 30 Jul 2009 11:50:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Incyte Corporation Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-326665.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator instructions Our first question is coming from Tom Russo with Robert W. Baird. Please state your question. Tom Russo &#8211; Robert W. Baird Good morning and congrats on all the progress in the last three months. Paul Friedman Thank you. Tom Russo &#8211; Robert...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 30 Jul 2009 10:50:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Incyte Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-300380.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. We will now be conducting the question-and-answer session Operator Instructions. Our first question comes from Mona Ashaya with JPMorgan. Please state your question. Mona Ashaya - JPMorgan Hi good morning. I'm here for Cory. A couple of questions. One on the acceptance of 13739 data...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Fri, 08 May 2009 12:18:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Incyte Corporation Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-270615.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Our first question comes from Thomas J. Russo - Robert W. Baird & Co. Thomas J. Russo - Robert W. Baird & Co.  Paul recognizing that there is a limited amount you can say with regard to your interactions with FDA and the SPA,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 18 Feb 2009 12:29:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/robert+w.+baird+%2526+co..html"><![CDATA[Robert W. Baird & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/enrollment.html"><![CDATA[Enrollment]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Incyte Corporation Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-223632.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions  Our first question comes from Cory Kasimov - J.P. Morgan. Cory Kasimov - J.P. Morgan Two questions here, both relating to the JAK II program.  Could you please discuss the difference if any in the burden of proof between the MF indication and...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Fri, 29 Aug 2008 10:06:17 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Cohen's SAC Capital Boosts Passive Stake in Incyte to 6.4%]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89943-cohen-s-sac-capital-boosts-passive-stake-in-incyte-to-6-4%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Lon Juricic submits:   In a 13G filing on Incyte Corporation INCY, Steven Cohen's SAC Capital disclosed a 6.4% stake (5,458,605 shares) in the company. This is up from the 1,105,000 share stake held at the quarter ended 3/31/08. A 13G indicates a 'passive investment'. Incyte Corporation operates as...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 08 Aug 2008 01:14:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Patni Computer Systems, Ltd., Incyte Corp., Pfizer Inc., ICICI Bank Ltd. and Tractor Supply Co]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_August_4/ai_n27967644]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Patni Computer Systems, Ltd. (NYSE: PTI), Incyte Corp. (Nasdaq: INCY), Pfizer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 04 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[blog]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/icici+bank+ltd..html"><![CDATA[ICICI Bank Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/patni+computer+systems+ltd..html"><![CDATA[Patni Computer Systems Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/tractor+supply+co..html"><![CDATA[Tractor Supply Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IBN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TSCO</category>
		<category domain="tickers">IBN,INCY,NDAQ,PFE,TSCO</category>
	</item>
	<item>
		<title><![CDATA[Incyte Corporation Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-230045.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions First question is from Richard Smith with JP Morgan. Please go ahead with your question. Richard Smith - JP Morgan Yes, good morning and congratulations on the progress so far. Just quick question on JAK2 myelofibrosis, can you just give us a sense of how...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 18 Feb 2008 16:00:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="tickers">INCY</category>
	</item>
</channel>
</rss>
